The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Hydroxyurea for the Treatment of Sickle Cell Anemia
Abstract
An 18-year-old woman with sickle cell anemia presents with recurrent painful crises, and treatment with hydroxyurea is recommended. Hydroxyurea causes a shift toward the production of red cells containing fetal hemoglobin. A possible increase in the risk of acute leukemia due to hydroxyurea therapy remains the subject of debate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationEffect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Castro, O., Brambilla, D., Thorington, B., Reindorf, C., Scott, R., Gillette, P., Vera, J., & Levy, P. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 808
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
Platt, O. S., Orkin, S. H., Dover, G., Beardsley, G. P., Miller, B., & Nathan, D. G. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111464 · Cited by 535
Self-citationFinazzi, G. (2005) · Blood · doi:10.1182/blood-2004-09-3426 · Cited by 431
Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea
Steinberg, M. H., Lu, Z.-H., Barton, F. B., Terrin, M. L., Charache, S., Dover, G. J., & Hydroxyurea, T. M. S. O. (1997) · Blood · doi:10.1182/blood.v89.3.1078 · Cited by 407
Control of globin gene expression during development and erythroid differentiation
Stamatoyannopoulos, G. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.11.007 · Cited by 393
Čokić, V. P., Smith, R. D., Beleslin‐Čokić, B. B., Njoroge, J. M., Miller, J. L., Gladwin, M. T., & Schechter, A. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16672 · Cited by 375
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study
Hankins, J. S., Ware, R. E., Rogers, Z. R., Wynn, L. W., Lane, P. A., Scott, J. P., & Wang, W. C. (2005) · Blood · doi:10.1182/blood-2004-12-4973 · Cited by 285
Hemoglobin and the Paracrine and Endocrine Functions of Nitric Oxide
Schechter, A. N., & Gladwin, M. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr023045 · Cited by 251
Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by Hydroxyurea
Letvin, N. L., Linch, D. C., Beardsley, G. P., McIntyre, K. W., & Nathan, D. G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404053101401 · Cited by 221
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
Zimmerman, S. A., Schultz, W. H., Burgett, S., Mortier, N. A., & Ware, R. E. (2007) · Blood · doi:10.1182/blood-2006-11-057893 · Cited by 217
Ware, R. E., Zimmerman, S. A., & Schultz, W. H. (1999) · Blood · doi:10.1182/blood.v94.9.3022 · Cited by 199
Ware, R. E., Zimmerman, S. A., Sylvestre, P. B., Mortier, N. A., Davis, J. S., Treem, W. R., & Schultz, W. H. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.04.058 · Cited by 170
Hydroxyurea and sickle cell anemia: effect on quality of life
Ballas, S. K., Barton, F. B., Waclawiw, M. A., Swerdlow, P., Eckman, J. R., Pegelow, C. H., Koshy, M., Barton, B. A., & Bonds, D. R. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-59 · Cited by 166
Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea
Ma, Q., Wyszynski, D. F., Farrell, J. J., Kutlar, A., Farrer, L. A., Baldwin, C. T., & Steinberg, M. H. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500433 · Cited by 144
Lanzkron, S., Haywood, C., Segal, J. B., & Dover, G. J. (2006) · American Journal of Hematology · doi:10.1002/ajh.20703 · Cited by 122
The effect of fetal hemoglobin on the survival characteristics of sickle cells
Franco, R. S., Yasin, Z., Palascak, M. B., Ciraolo, P., Joiner, C. H., & Rucknagel, D. L. (2006) · Blood · doi:10.1182/blood-2005-09-008318 · Cited by 119
Effect of hydroxyurea on growth in children with sickle cell anemia: Results of the HUG-KIDS study
Wang, W. C., Helms, R. W., Lynn, H., Redding‐Lallinger, R., Gee, B. E., Ohene‐Frempong, K., Smith‐Whitley, K., Waclawiw, M. A., Vichinsky, E. P., Styles, L. A., et al. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.121383 · Cited by 114
Cost-effectiveness of hydroxyurea in sickle cell anemia
Moore, R. D., Charache, S., Terrin, M. L., Barton, F. B., & Ballas, S. K. (2000) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(200005)64:1<26::aid-ajh5>3.0.co;2-f · Cited by 104
Zumberg, M. S., Reddy, S., Boyette, R. L., Schwartz, R. J., Konrad, T. R., & Lottenberg, R. (2005) · American Journal of Hematology · doi:10.1002/ajh.20353 · Cited by 79
Ballas, S. K., Marcolina, M. J., Dover, G. J., & Barton, F. B. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01339.x · Cited by 71
The Influence of Renal Function on Hydroxyurea Pharmacokinetics in Adults With Sickle Cell Disease
Yan, J., Ataga, K. I., Kaul, S., Olson, J. S., Grasela, D. M., Gothelf, S., Kutlar, A., & Orringer, E. P. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273526 · Cited by 48
The family study of otitis media: Design and disease and risk factor profiles
Daly, K. A., Rich, S. S., Levine, S. C., Margolis, R. H., Le, C. T., Lindgren, B. R., & Giebink, G. S. (1996) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1996)13:5<501::aid-gepi6>3.0.co;2-4 · Cited by 48
Cited by
Lettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Reactivation of developmentally silenced globin genes by forced chromatin looping
Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443
“If a similar degree of reactivation of fetal globin genes could be achieved in adult human erythroid cells, this would be highly therapeutically relevant (Platt, 2008).”
BackgroundHemoglobin research and the origins of molecular medicine
Schechter, A. N. (2008) · Blood · doi:10.1182/blood-2008-04-078188 · Cited by 381
Barabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Anemia: progress in molecular mechanisms and therapies
Sankaran, V. G., & Weiss, M. J. (2015) · Nature Medicine · doi:10.1038/nm.3814 · Cited by 281
Metadata
- Authors
- Platt, O. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-03-27
- Volume
- 358
- Issue
- 13
- Pages
- 1362-1369
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2050711676
- Cited by
- 357
- References
- 27
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.